Skip to content

Effects of Virtual Reality Versus Motor Imagery Versus Routine Physical Therapy in Patients With Parkinson's Disease.

Effects of Virtual Reality Versus Motor Imagery Versus Routine Physical Therapy in Patients With Parkinson's Disease: A Randomised Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04884646
Enrollment
60
Registered
2021-05-13
Start date
2020-05-01
Completion date
2021-06-12
Last updated
2021-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease

Keywords

Parkinson, Virtual Reality, Motor Imagery, Routine Physical Therapy

Brief summary

The aim of this study is to investigate the effects of VR and MI techniques in addition to routine physical therapy on motor skills, balance and ADL in patients with Parkinson's disease.

Detailed description

Parkinson's disease is one of the most common, insidious neurological disorders with major motor symptoms, including bradykinesia, resting tremors, rigidity, and postural disorders. Virtual reality and motor imagery are among the more innovative techniques for rehabilitation of patients with Parkinson's disease that promote motor learning through both explicit and implicit processes.This study is unique in that it examines the effects of VR versus MI on motor skills, balance, and daily living activities in individuals with Parkinson's disease

Interventions

OTHERVR with Routine physical therapy and Virtual reality

VR group will be treated with virtual reality for 15 to 20 minutes along with routine physical therapy for 40 minutes session 3 days/week for 12 weeks

OTHERMotor Imagery with Routine physical therapy

MI group will be treated with virtual reality for 15 to 20 minutes along with routine physical therapy for 40 minutes session 3 days/week for 12 weeks

OTHERRoutine physical therapy

Group A will be given routine physical therapy in 40-min sessions and 20 min of walking and cycling with a short period of rest, every alternate day (3 days per week) for 12 weeks

Sponsors

Riphah International University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

The study would be single blinded as accessor of the study would be kept blind of the treatment group to which patient would be allocated.After the complete initial screening process, every recruited patient will be accessed by an independent assessor, expert will use outcome measuring tools. his will be recorded as baseline measurement assessment

Eligibility

Sex/Gender
ALL
Age
50 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Idiopathic Parkinson's disease * Modified Hoehn and Yahr Scale(H&Y stages I to III) * Between the ages of 50 and 80 years of both genders * Independent in transfers * A score equal to or greater than 24 on the Mini-Mental State Examination (MMSE), and * Previous lack of participation in balance or motor training.

Exclusion criteria

* History of any neurological conditions such as stroke, multiple sclerosis, epilepsy other than Parkinson's disease, * History of orthopedic issues such as pain, fracture, or lower limb pathology, * History of visual abnormalities, * History of any chronic or cardiovascular pathology that can interfere with the transfer procedure or can affect the training sessions, * The participants having severe dyskinesia or on-off phases, * Previous history of surgery for PD, * History of virtual games used for treatment in the past three months, and * Virtual game phobia.

Design outcomes

Primary

MeasureTime frameDescription
Unified Parkinson's disease Rating Scale Part II3 monthsThis is a subjective instrument that is widely used in clinical settings for patients with Parkinson's disease. This scale comprises 31 elements, which are divided into three sub-scales: Sub-scale II comprises the evaluation of activities in daily living. A possible maximum of 199 points can be scored on this scale. A score of 199 refers to complete disability and 0 refers to the absence of disability .
Unified Parkinson's disease Rating Scale Part III3 monthsThis is a subjective instrument that is widely used in clinical settings for patients with Parkinson's disease. This scale comprises 31 elements, which are divided into three sub-scales and sub-scale III evaluates the motor system. A possible maximum of 199 points can be scored on this scale. A score of 199 refers to complete disability and 0 refers to the absence of disability
Berg Balance Scale (BBS)3 monthsThe scale has been established as the most widely used assessment tool in clinical settings to identify changes in balance performance. A score of less than 45 is considered a limit for the risk of falling, while a score of 56 relates to functional balance

Secondary

MeasureTime frameDescription
Activities-specific Balance Confidence Scale (ABC):3 monthsThis scale is used as a predictor of falls in patients with neurological deficits. Patients are rated from 0% to 100%, with 0% interpreted as not at all safe and 100% as completely safe

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026